OM
Outset Medical, Inc.
NASDAQ · USHealthcareMedical - Devices
$4.06-3.33%
Price as of Jul 20, 2026
OM profitability
Outset Medical, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 40.6%
- EBITDA margin
- -48.6%
- EBIT margin
- -57.2%
- Net margin
- -63.7%
- Free cash flow margin
- -29.1%
Returns
- Return on equity
- -67.0%
- Return on assets
- -30.0%
- Return on invested capital
- -31.5%
- Asset turnover
- 0.46x
Cash efficiency
- Cash from operations
- -$33.5M
- Cash per share
- $8.45
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.